BIOPHARM: all contributions
2023–2024 · Reported individual contributions grouped by employer.
These are contributions by individuals, not by their employer, industry, or location. Refunds remain negative; memo-only rows are marked and are not additional money.
← Back to BIOPHARM| # | Reported contributor / location | Reported employer / occupation | Recipient / reporting committee | Date ↕ | Amount ↑ | Election | Filing details / source |
|---|---|---|---|---|---|---|---|
| 101 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2023-07-18 | $15 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1753657FEC filing ↗ |
| 102 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2024-11-10 | $16 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1866521 · amendedFEC filing ↗ |
| 103 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2024-10-19 | $16 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1866521 · amendedFEC filing ↗ |
| 104 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2023-10-15 | $16 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1753657FEC filing ↗ |
| 105 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2024-06-16 | $16 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1804804FEC filing ↗ |
| 106 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2024-09-16 | $16 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1853891 · amendedFEC filing ↗ |
| 107 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2024-11-08 | $16 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1866521 · amendedFEC filing ↗ |
| 108 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2023-12-16 | $16 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1753657FEC filing ↗ |
| 109 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2024-07-16 | $16 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1812288FEC filing ↗ |
| 110 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2024-11-15 | $16 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1866521 · amendedFEC filing ↗ |
| 111 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2024-06-22 | $16 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1804804FEC filing ↗ |
| 112 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2023-12-11 | $16 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1753657FEC filing ↗ |
| 113 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2023-12-22 | $16 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1753657FEC filing ↗ |
| 114 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2024-08-16 | $16 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1849321 · amendedFEC filing ↗ |
| 115 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2024-11-16 | $16 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1866521 · amendedFEC filing ↗ |
| 116 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2024-09-08 | $16 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1853891 · amendedFEC filing ↗ |
| 117 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2024-11-19 | $16 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1866521 · amendedFEC filing ↗ |
| 118 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2024-12-16 | $16 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1873232FEC filing ↗ |
| 119 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2023-09-12 | $16 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1753657FEC filing ↗ |
| 120 | FUJIKAWA, ELLENENCINITASCA92024 | CONSULTANTBIOPHARM | HMPC00495028 | 2024-08-31 | $16 | Primary (P) | * EARMARKED CONTRIBUTION: SEE BELOWFiling 1853891 · amendedFEC filing ↗ |
This small employer group is read directly through the employer index, then sorted and paginated. Only the latest version within matching employer records is shown; amendments that change the employer may affect this grouping. Raw reported names and filing values are preserved. This list covers locally ingested FEC individual-contribution records, not undisclosed or unitemized contributor identities.